Guardian Therapeutics, LLC
Therapeutic programs targeting multiple disease pathways
Follows are private to you and power your alerts
Updated · guardiantherapeutics.com
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2017
- Latest Form D
- $20M, Aug 2018
- Total capital
- $30M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $30M
- 2 Form D · last Aug 2018
- 98 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$20M
- Private capital raisedForm D · SEC · 1st filing$10M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Christa Badger SchmidtExecutive OfficerNamed in SEC Form D filings
- Clarke Badger AtwellExecutive OfficerNamed in SEC Form D filings
- James C. Gilbert, MDExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingGPC3 Aptamers And Variants And Use ThereofUSPTOApplication 18252763
- PendingFatty Acid Conjugates Of Nucleic AcidsUSPTOApplication 18599808
- PendingRna Polymerase For Synthesis Of Modified RnaUSPTOApplication 17275740
Show all 8 patent records
- GPC3 Aptamers And Variants And Use ThereofSep 11, 2025 · Application 18252763Pending
- Fatty Acid Conjugates Of Nucleic AcidsJul 25, 2024 · Application 18599808Pending
- Rna Polymerase For Synthesis Of Modified RnaFeb 24, 2022 · Application 17275740Pending
- Fatty Acid ConjugationsApplication 63242679Pending
- GPC3 Aptamers And Variants And Use ThereofApplication 63113640Pending
- Rna Polymerase For Synthesis Of Modified RnaApplication PCTUS2019050777Pending
- Fatty Acid ConjugationsApplication PCTUS2022076198Pending
- GPC3 Aptamers And Variants And Use ThereofApplication PCTUS2021059062Pending
Related companies, and why
- Pasithea Therapeutics Corp.Similar federal contract value in Biotech · null in contracts
- Athos Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- STEM CELL THERAPEUTICS CORPSimilar federal contract value in Biotech · null in contracts
- Nexo TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Cadrenal Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Immunitas TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .